In April, a study in the Canadian Medical Association
Journal found patients on bisphosphonates
were at higher risk of developing the eye disorders scleritis and uveitis. And this week the FDA announced that
the bisphosphonates may stop working after a while. The FDA's analysis
"found little if any benefit from the drugs after three to five years of
use," reported the New York Times.
As many as 60 percent to 70 percent of current users
"would be candidates for stopping the drugs after three to five
years," reports the Times --a
diplomatic way of saying they were taking drugs for naught.
Why did the FDA rush to approve bone drugs which turned out to have links to cancer, jawbone death, heart problems, intractable pain and eye disorders? Drugs which actually cause fractures and apparently cease working while patients take them? Why did it foster Merck's apparent marketing plan of making quick money before risks surfaced? See: Vioxx? END
Martha Rosenberg's first book, Born with a Junk Food Deficiency: How Flaks, Quacks, and Hacks Pimp the Public Health, was published last week.
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).
9
7
5
